Related Experiment Video
Updated: Aug 18, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis
1U-370 INSERM, Necker Institute, 75015 Paris, France.
Abstract:
We have used the Hepatitis B Virus DNA genome as a probe to identify genes clonally mutated in vivo, in human liver cancers. In a tumor, HBV-DNA was found to be integrated into the gene encoding Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA), which pumps calcium, an important intracellular messenger for cell viability and growth, from the cytosol to the endoplasmic reticulum. The HBV X gene promoter cis-activates chimeric HBV X/SERCA1 transcripts, with splicing of SERCA1 exon 11, encoding C-terminally truncated SERCA1 proteins. Two chimeric HBV X/SERCA1 proteins accumulate in the tumor and form dimers. In vitro analyses have demonstrated that these proteins localize to the ER, determine its calcium depletion and induce cell death. We have also shown that these biological effects are related to expression of the SERCA, rather than of the viral moiety. This report involves for the first time the expression of mutated SERCA proteins in vivo in a tumor cell proliferation and in vitro in the control of cell viability. Oncogene (2000).
Insights
Hepatitis B Virus DNA integration into the Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA) gene in liver cancer leads to mutated SERCA proteins. These mutated proteins disrupt calcium homeostasis, driving tumor cell proliferation and death.
Area of Science:
- Hepatology
- Molecular Biology
- Oncology
Background:
- Hepatitis B Virus (HBV) infection is a major cause of hepatocellular carcinoma.
- Gene mutations are critical in the development of human liver cancers.
- Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA) regulates intracellular calcium levels, vital for cell function.
Purpose of the Study:
- To identify genes clonally mutated in vivo in human liver cancers using HBV DNA as a probe.
- To investigate the functional consequences of HBV DNA integration into the SERCA gene.
Main Methods:
- Utilized HBV DNA as a probe for identifying mutated genes in human liver tumors.
- Analyzed HBV DNA integration sites and characterized chimeric HBV X/SERCA1 transcripts.
- Performed in vitro experiments to assess the localization, dimerization, and cellular effects of chimeric SERCA1 proteins.
Main Results:
- HBV DNA was found integrated into the SERCA gene in a human liver tumor.
- Chimeric HBV X/SERCA1 transcripts produced truncated SERCA1 proteins that accumulated and formed dimers in tumor cells.
- These mutated SERCA proteins localized to the ER, depleted its calcium, and induced cell death, with effects linked to SERCA expression.
Conclusions:
- This study reports the first in vivo expression of mutated SERCA proteins in tumor cell proliferation.
- Mutated SERCA proteins resulting from HBV integration play a role in controlling cell viability and contribute to liver cancer development.
- The findings highlight a novel mechanism involving SERCA dysfunction in HBV-associated hepatocarcinogenesis.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Caspases
The Intrinsic Apoptotic Pathway
Hepatitis
Cellular Injury V: Apoptosis and Autophagy

